Skip to main content

and
  1. No Access

    Article

    Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients

    U Platzbecker, H K Al-Ali, N Gattermann, D Haase, V Janzen, J Krauter, K Götze in Leukemia (2014)